Ciprofloxacin Tablet, Film Coated
Product Images NDC 59651-866

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 59651-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg (30 Tablets Bottle))

Package Label-principal Display Panel (250 mg (30 Tablets Bottle))
This is a description for Ciprofloxacin Tablets, USP by Aurobindo. The tablets come in a pack of 30 and contain 291 mg of Ciprofloxacin. The recommended storage temperature is between 20°C to 25°C. The medication guide is provided separately and the usual dosage should be followed as per the package insert for proper administration. The medication is distributed by Aurobindo Pharma USA.*
FDA Label Image

Package Label-principal Display Panel (500 mg (30 Tablets Bottle))

Package Label-principal Display Panel (500 mg (30 Tablets Bottle))
This text contains information about Ciprofloxacin Tablets, USP, with details such as dosage, administration instructions, storage conditions, manufacturer information, and packaging details. It also instructs the pharmacist to dispense the medication with a provided medication guide. The tablets contain 582 mg of ciprofloxacin hydrochloride monohydrate equivalent to 500 mg of ciprofloxacin USP. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). The text also mentions the usual dosage and administration details. Additionally, it states that during packing, the GTIN, Serial Number, Expiry Date, and LOT will be printed in human-readable format along with 2D coding.*
FDA Label Image

Package Label-principal Display Panel (750 mg (50 Tablets Bottle))

Package Label-principal Display Panel (750 mg (50 Tablets Bottle))
This text provides information on Ciprofloxacin Tablets, USP. Each film-coated tablet contains 873mg of ciprofloxacin hydrochloride monohydrate equivalent to 750 mg ciprofloxacin USP. The usual dosage information is available in the package insert along with storage instructions. The medication guide is advised to be dispensed separately. The tablets are distributed by Aurobindo Pharma USA, Inc., and are made in India. The website for printing medication guides is provided for further reference.*
FDA Label Image

Chemical Structure (Ciprofloxacin Str1)

FDA Label Image

Chemical Structure (Ciprofloxacin Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.